Related Experiment Video
Updated: Oct 5, 2026

A Colorimetric Assay that Specifically Measures Granzyme B Proteolytic Activity: Hydrolysis of Boc-Ala-Ala-Asp-S-Bzl
Published on: November 28, 2014
Perforin and granzyme B induce apoptosis in FasL-resistant colon carcinoma cells
D Vermijlen1, C J Froelich, D Luo
1Laboratory for Cell Biology and Histology, Free University Brussels (VUB), Belgium. dvermijl@cyto.vub.ac.be
Abstract:
Cytotoxic lymphocytes may induce apoptosis in their target cells by the FasL (Fas ligand) pathway or the perforin/granzyme B pathway. It has been shown that Fas-expressing colon carcinoma (CC) cells are resistant to FasL-mediated apoptosis. The aims of this study were to determine whether CC cells are also resistant to perforin/granzyme B and whether the FasL resistance lies upstream of caspase-3 activation. The resistance of the Fas-expressing rat CC531s cells to the FasL pathway was confirmed by treating them with recombinant human soluble FasL, using rat hepatocytes as a positive control. The intracellular delivery of granzyme B by sublytic concentrations of perforin, on the other hand, resulted in many features of apoptosis (chromatin condensation, nucleus fragmentation, loss of microvilli and internucleosomal DNA fragmentation) within 3 h. Since both the FasL and perforin/granzyme B pathways converge at caspase-3, we measured caspase-3 activity to learn whether the FasL resistance was due to failure to activate this crucial executioner. Caspase-3 activation occurred in CC531s cells after perforin/granzyme B treatment, but not after the addition of recombinant FasL. Furthermore, we showed that caspase-3 activity is involved in the execution of perforin/granzyme-B-induced apoptosis in CC531 s cells, since the cell-permeable caspase-3 inhibitor Z-DEVD-FMK abrogated DNA fragmentation. Together, these results suggest that CC cells are sensitive to perforin/granzyme-B-induced apoptosis by activating caspase-3 and FasL resistance lies upstream of this executioner caspase.
Insights
Colon carcinoma cells resist Fas ligand-induced apoptosis but are sensitive to perforin/granzyme B-induced apoptosis. This resistance occurs upstream of caspase-3 activation, indicating a specific pathway vulnerability.
Area of Science:
- Immunology
- Cell Biology
- Cancer Research
Background:
- Cytotoxic lymphocytes induce apoptosis via Fas ligand (FasL) or perforin/granzyme B pathways.
- Fas-expressing colon carcinoma (CC) cells exhibit resistance to FasL-mediated apoptosis.
Purpose of the Study:
- Investigate CC cell sensitivity to the perforin/granzyme B pathway.
- Determine if FasL resistance precedes caspase-3 activation.
Main Methods:
- Treated Fas-expressing rat CC531s cells with recombinant human soluble FasL and perforin/granzyme B.
- Assessed apoptosis features (chromatin condensation, DNA fragmentation) and caspase-3 activity.
- Utilized a caspase-3 inhibitor (Z-DEVD-FMK) to evaluate pathway involvement.
Main Results:
- CC531s cells showed apoptosis features upon perforin/granzyme B treatment.
- Caspase-3 activation occurred after perforin/granzyme B but not FasL treatment.
- Caspase-3 inhibition blocked perforin/granzyme B-induced DNA fragmentation.
Conclusions:
- Colon carcinoma cells are sensitive to perforin/granzyme B-induced apoptosis via caspase-3 activation.
- FasL resistance in CC cells is located upstream of caspase-3 activation.
Related Concept Videos
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized by phagocytes.
Apoptosis
Caspases
Cellular Injury V: Apoptosis and Autophagy

